로그인 회원가입
icon_bulk_order대량 주문 조회 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > IL-2 R gamma

IL-2 R gamma

요약

Name:Interleukin-2 receptor subunit gamma
Target Synonym:Common Cytokine Receptor Gamma Chain,IL-2R Subunit Gamma,IL2RG,SCIDX,CD132,CIDX,IL-2RG,IMD4,Nonfunctional Common Cytokine Receptor Gamma Chain,Combined Immunodeficiency, X-Linked,Interleukin 2 Receptor Subunit Gamma,Interleukin-2 Receptor Subunit Gamma,Severe Combined Immunodeficiency,Cytokine Receptor Common Subunit Gamma,CD132 Antigen,GammaC,Interleukin 2 Receptor, Gamma,IL-2 Receptor Subunit Gamma,SCIDX1,P64
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:10
Lastest Research Phase:Phase 2 Clinical

제품 리스트 비교 또는 구매

일부의 생물활성 데이터

ILG-H85E8-Cell-based assay
Human FcRn Heterodimer Protein Cell_Base

Biotinylated Human IL-2 R gamma, His,Avitag (Cat. No. ILG-H85E8) inhibits the IL-2-dependent proliferation of Mo7e cells. The EC50 for this effect is 4.08-5.90 µg/mL in the presence of 10 µg/mL of human IL-2 R beta and 50 ng/mL of human IL-2 (Routinely tested).

ILG-C52H9-MALS-HPLC
Cynomolgus IL-2 R gamma, His Tag (Cat. No. ) MALS images

The purity of Cynomolgus IL-2 R gamma, His Tag (Cat. No. ILG-C52H9) is more than 85% and the molecular weight of this protein is around 50-65 kDa verified by SEC-MALS.

  • Background
    IL-2R is a heterotrimeric protein binds and responds to the cytokine IL-2. Three distinct chains of IL-2R, termed as α, β and γ, which are non-covalently associated are identified. The α and β chains are involved in binding IL-2, while signal transduction following cytokine interaction is carried out by the γ chain, along with the β subunit. The α chain of the IL-2R can bind to the β chain before receptor interaction with IL-2. The γ chain alone has a very weak affinity for IL-2, but after the ligand is bound to the α/β heterodimer, the γ chain becomes recruited to the complex to form a very stable macromolecular quaternary ligand/receptor complex. Interleukin-2 receptor subunit gamma (IL2RG), also known as cytokine receptor common subunit gamma, CD antigen CD132, gammaC, p64, which belongs to the type I cytokine receptor family or type 5 subfamily. IL2RG is located on the surface of immature blood-forming cells in bone marrow. Defects in IL2RG are the cause of severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID).
  • Clinical and Translational Updates
      
  • Please contact us via TechSupport@acrobiosystems.com if you have any question on this product.

    ILA-M52H3-MALS-HPLC
    Mouse IL-2 R gamma, His Tag (Cat. No. ) MALS images

    The purity of Mouse IL-2 R gamma, His Tag (Cat. No. ILA-M52H3) is more than 85% and the molecular weight of this protein is around 45-55 kDa verified by SEC-MALS.

Synonym Name

IL2RG,CD132,CIDX,IMD4,P64,SCIDX,SCIDX1,gammaC

Background

IL-2R is a heterotrimeric protein binds and responds to the cytokine IL-2. Three distinct chains of IL-2R, termed as α, β and γ, which are non-covalently associated are identified. The α and β chains are involved in binding IL-2, while signal transduction following cytokine interaction is carried out by the γ chain, along with the β subunit. The α chain of the IL-2R can bind to the β chain before receptor interaction with IL-2. The γ chain alone has a very weak affinity for IL-2, but after the ligand is bound to the α/β heterodimer, the γ chain becomes recruited to the complex to form a very stable macromolecular quaternary ligand/receptor complex. Interleukin-2 receptor subunit gamma (IL2RG), also known as cytokine receptor common subunit gamma, CD antigen CD132, gammaC, p64, which belongs to the type I cytokine receptor family or type 5 subfamily. IL2RG is located on the surface of immature blood-forming cells in bone marrow. Defects in IL2RG are the cause of severe combined immunodeficiency X-linked T-cell-negative/B-cell-positive/NK-cell-negative (XSCID).

Clinical and Translational Updates

임상 약품 정보

Name Research Code Research Phase Company Indications Clinical Trials
TYF-IL-2Rg gene-modified autologous stem cells (Shenzhen Geno-Immune Medical Institute) Phase 2 Clinical Shenzhen Geno-Immune Medical Institute X-Linked Combined Immunodeficiency Diseases Details
Recombinant human interleukin 15(Beijing Kawin) Phase 1 Clinical Beijing Kawin Technology Share-Holding Co Ltd Solid tumours Details
MB-107 MB-107; IND-14570 Phase 2 Clinical St. Jude Children'S Research Hospital, National Institute Of Allergy And Infectious Diseases (Niaid), National Heart, Lung And Blood Institute, National Institute of Health, Islamabad Immunologic Deficiency Syndromes Details
NL-201 (Neoleukin Therapeutics) NL-201 Neoleukin Therapeutics Inc Details
REGN-7257 REGN-7257 Regeneron Pharmaceuticals Inc Details
BJ-001(Boji Biomedical Technology) BJ-001 Phase 1 Clinical Boji Biomedical Technology (Hangzhou) Co Ltd Solid tumours; Communicable Diseases; Neoplasm Metastasis Details
Simlukafusp alfa FAP-IL2v; RG-7461; aFAP-IL2v; RO-6874281; FAP-IL2v FP F. Hoffmann-La Roche Ltd Details
IAP-0971 IAP-0971 Phase 2 Clinical Shenghe (China) Biopharmaceutical Co Ltd Solid tumours; Neoplasms Details
BNZ-1 BNZ132-1-40; BNZ-1; BNZ132-1; BNZ-01 Phase 2 Clinical Bioniz Alopecia; Alopecia Areata; Lymphoma, T-Cell, Cutaneous; Leukemia, Large Granular Lymphocytic Details
THOR-707 THOR-707; SAR-444245 Phase 2 Clinical Synthorx Intestinal Neoplasms; Stomach Neoplasms; Squamous Cell Carcinoma of Head and Neck; Lymphoma, Large B-Cell, Diffuse; Skin Neoplasms; Hodgkin Disease; Mesothelioma; Colorectal Neoplasms; Esophageal Squamous Cell Carcinoma; Carcinoma, Squamous Cell; Melanoma; Neoplasm Metastasis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Hepatocellular Details

This web search service is supported by Google Inc.

totop